NO955313D0 - Anvendelse av ropivacain i fremstillingen av et farmasöytikum med analgetisk effekt som har minimal motorisk blokkering - Google Patents

Anvendelse av ropivacain i fremstillingen av et farmasöytikum med analgetisk effekt som har minimal motorisk blokkering

Info

Publication number
NO955313D0
NO955313D0 NO955313A NO955313A NO955313D0 NO 955313 D0 NO955313 D0 NO 955313D0 NO 955313 A NO955313 A NO 955313A NO 955313 A NO955313 A NO 955313A NO 955313 D0 NO955313 D0 NO 955313D0
Authority
NO
Norway
Prior art keywords
ropivacaine
pharmaceutical
preparation
pct
analgesic effect
Prior art date
Application number
NO955313A
Other languages
English (en)
Other versions
NO955313L (no
Inventor
Arne Torsten Eek
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20390432&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO955313(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astra Ab filed Critical Astra Ab
Publication of NO955313D0 publication Critical patent/NO955313D0/no
Publication of NO955313L publication Critical patent/NO955313L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Insulation, Fastening Of Motor, Generator Windings (AREA)
  • Electromechanical Clocks (AREA)
  • Particle Accelerators (AREA)
  • Air Conditioning Control Device (AREA)
  • Steroid Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NO955313A 1993-06-28 1995-12-27 Anvendelse av ropivacain i fremstillingen av et farmasöytikum med analgetisk effekt som har minimal motorisk blokkering NO955313L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE19939302218A SE9302218D0 (sv) 1993-06-28 1993-06-28 New use
PCT/SE1994/000496 WO1995000148A1 (en) 1993-06-28 1994-05-26 Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade

Publications (2)

Publication Number Publication Date
NO955313D0 true NO955313D0 (no) 1995-12-27
NO955313L NO955313L (no) 1995-12-27

Family

ID=20390432

Family Applications (1)

Application Number Title Priority Date Filing Date
NO955313A NO955313L (no) 1993-06-28 1995-12-27 Anvendelse av ropivacain i fremstillingen av et farmasöytikum med analgetisk effekt som har minimal motorisk blokkering

Country Status (33)

Country Link
US (2) US5670524A (no)
EP (1) EP0706395B1 (no)
JP (1) JP3725541B2 (no)
CN (1) CN1074918C (no)
AT (1) ATE216237T1 (no)
BR (1) BR9406865A (no)
CA (1) CA2165446C (no)
CZ (1) CZ283300B6 (no)
DE (2) DE706395T1 (no)
DK (1) DK0706395T3 (no)
EE (1) EE03205B1 (no)
ES (1) ES2099048T3 (no)
FI (1) FI956269A (no)
GR (1) GR970300013T1 (no)
HK (1) HK1010344A1 (no)
HU (1) HU218949B (no)
IL (1) IL110006A (no)
IS (1) IS4174A (no)
LT (1) LT3449B (no)
LV (1) LV12918B (no)
MY (1) MY119360A (no)
NO (1) NO955313L (no)
NZ (1) NZ268110A (no)
PH (1) PH31258A (no)
PL (1) PL175518B1 (no)
PT (1) PT706395E (no)
RU (1) RU2152215C1 (no)
SA (1) SA94150010B1 (no)
SE (1) SE9302218D0 (no)
SG (1) SG49078A1 (no)
SK (1) SK280111B6 (no)
TW (1) TW285640B (no)
WO (1) WO1995000148A1 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302218D0 (sv) * 1993-06-28 1993-06-28 Ab Astra New use
US5945435A (en) * 1997-07-21 1999-08-31 Darwin Discovery Limited Levobupivacaine and its use
US20060270708A1 (en) * 2005-05-25 2006-11-30 Navinta Llc Novel process for preparation of isotonic aqueous injection of ropivacaine
USRE46397E1 (en) 2007-11-07 2017-05-09 Svip5 Llc Slow release of organic salts of local anesthetics for pain relief
CA2873138A1 (en) * 2012-05-10 2013-11-14 Cellixbio Private Limited Compositions and methods for the treatment of local pain
RU2678433C2 (ru) 2012-05-10 2019-01-29 Пейнреформ Лтд. Депо-составы гидрофобного активного ингредиента и способы их получения
KR20150119468A (ko) 2013-02-28 2015-10-23 더미라, 인코포레이티드 글리코피롤레이트 염
US9006462B2 (en) 2013-02-28 2015-04-14 Dermira, Inc. Glycopyrrolate salts
US8558008B2 (en) 2013-02-28 2013-10-15 Dermira, Inc. Crystalline glycopyrrolate tosylate

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3379266D1 (en) * 1983-08-01 1989-04-06 Astra Laekemedel Ab L-n-n-propylpipecolic acid-2,6-xylidide and method for preparing the same
SE9302218D0 (sv) * 1993-06-28 1993-06-28 Ab Astra New use

Also Published As

Publication number Publication date
NO955313L (no) 1995-12-27
LTIP1958A (en) 1995-01-31
NZ268110A (en) 1999-06-29
AU692161B2 (en) 1998-06-04
SK280111B6 (sk) 1999-08-06
RU2152215C1 (ru) 2000-07-10
DE706395T1 (de) 1997-09-04
ES2099048T3 (es) 2002-11-16
CZ336495A3 (en) 1996-06-12
AU7086694A (en) 1995-01-17
BR9406865A (pt) 1996-03-26
HK1010344A1 (en) 1999-06-17
MY119360A (en) 2005-05-31
CN1074918C (zh) 2001-11-21
CN1126435A (zh) 1996-07-10
PH31258A (en) 1998-06-18
DE69430427D1 (de) 2002-05-23
WO1995000148A1 (en) 1995-01-05
IS4174A (is) 1994-12-29
IL110006A (en) 1999-01-26
SK164695A3 (en) 1996-07-03
PL312198A1 (en) 1996-04-01
ES2099048T1 (es) 1997-05-16
GR970300013T1 (en) 1997-05-31
SA94150010B1 (ar) 2006-04-04
EP0706395A1 (en) 1996-04-17
CA2165446A1 (en) 1995-01-05
EP0706395B1 (en) 2002-04-17
CA2165446C (en) 2005-07-05
JPH09500620A (ja) 1997-01-21
HUT75115A (en) 1997-04-28
DE69430427T2 (de) 2002-11-14
HU9503692D0 (en) 1996-02-28
HU218949B (hu) 2001-01-29
LV12918B (en) 2003-03-20
IL110006A0 (en) 1994-11-11
FI956269A0 (fi) 1995-12-27
ATE216237T1 (de) 2002-05-15
PL175518B1 (pl) 1999-01-29
FI956269A (fi) 1995-12-27
US5670524A (en) 1997-09-23
PT706395E (pt) 2002-09-30
LT3449B (en) 1995-10-25
DK0706395T3 (da) 2002-07-22
EE03205B1 (et) 1999-08-16
SE9302218D0 (sv) 1993-06-28
CZ283300B6 (cs) 1998-02-18
SG49078A1 (en) 1998-05-18
US5834489A (en) 1998-11-10
TW285640B (no) 1996-09-11
JP3725541B2 (ja) 2005-12-14

Similar Documents

Publication Publication Date Title
NO960067D0 (no) Nytt farmasöytisk preparat
SE9401728D0 (sv) New compounds II
NO308644B1 (no) Anvendelse av 4-aminopyridin for fremstilling av et farmasøytisk preparat
NO955313L (no) Anvendelse av ropivacain i fremstillingen av et farmasöytikum med analgetisk effekt som har minimal motorisk blokkering
DK0866711T3 (da) Anvendelse af 6-methyl-5-oxo-3-thiomorpholinylcarbonyl-L-histidyl-L-prolinamid til fremstilling af et farmaceutisk præparat til modvirkning af sövnapnö
SE9504267D0 (sv) New therapeutic use
DK0863752T3 (da) Anvendelse af alkylaminderivater såsom terbinafin ved fremstillingen af et lægemiddel til behandling af ledsagende sygdomme af en helicobacter pylori-infektion.
KR960700053A (ko) 방사선회복제로서 리루졸의 이용(application of riluzole as a radiorestorer)
MX9804798A (es) Nuevos compuestos con efecto analgesico.
MX9804797A (es) Nuevos compuestos con efecto analgesico.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application